Loading
Total declarations
Company
▲ Purchases (11 ops.)
▼ Sales (1 ops.)
Latest filing published 07 Mar 2016 for Targeted Medical Pharma, Inc., €25k.
Insider track record
Disclosed buys
11
Disclosed sells
1
Signal history
No signal scores available.
Closed purchases
Market purchases
11
Positive at T+90
55%
Median T+90
+9.7%
Based on 11 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -93.8%Entry US$0.40 · Close at T+365 US$0.03
- -72.2%Entry US$0.72 · Close at T+365 US$0.20
- -47.8%Entry US$0.67 · Close at T+365 US$0.35
- -35.5%Entry US$0.62 · Close at T+365 US$0.40
- -57.9%Entry US$0.95 · Close at T+365 US$0.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Kim Giffoni: trading record in brief
Kim Giffoni appears in our data through filings on Targeted Medical Pharma, Inc. shares, published by SEC (Form 4). The record holds 16 filings, for trades running from 19 August 2013 to 4 March 2016.
In open-market terms, that means 11 purchases worth €15k on one side and 1 sale worth €121 on the other. The net balance comes to €15k on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants.
A typical purchase (the median) is worth €653. After 11 purchases with a full 90-day history, the hit rate stands at 55% and the median 90-day move at +9.7%. Past outcomes like these are no guarantee of what comes next.
The newest entry dates from 7 March 2016: a share grant of €25k, in Targeted Medical Pharma, Inc. The last insider purchase was made public on 24 November 2014, 4,352 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Kim Giffoni
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
547,500 shares@ US$0.05100.0% of flowCommon StockSEC:0001493152-16-007869:0
8,580 shares@ US$0.015Common StockSEC:0001493152-15-005866:0
68,077 shares@ US$0.20Common StockSEC:0001493152-15-004370:0
68,077 shares@ US$0.20Common StockSEC:0001493152-15-002240:0
500 shares@ US$0.50Common StockSEC:0001493152-14-003930:0
Canonical exit: 22 Feb 2015 (T+90)
200 shares@ US$0.50Common StockSEC:0001493152-14-003930:1
Canonical exit: 22 Feb 2015 (T+90)
1,000 shares@ US$0.83Common StockSEC:0001493152-14-001085:0
Canonical exit: 8 Jul 2014 (T+90)
4,000 shares@ US$0.835Common StockSEC:0001493152-14-001085:1
Canonical exit: 8 Jul 2014 (T+90)
1,000 shares@ US$0.90Common StockSEC:0001144204-13-067548:0
Canonical exit: 12 Mar 2014 (T+90)
3,500 shares@ US$0.83Common StockSEC:0001144204-13-066784:0
Canonical exit: 9 Mar 2014 (T+90)
7,480 shares@ US$0.90Common StockSEC:0001144204-13-066784:1
Canonical exit: 10 Mar 2014 (T+90)
1,000 shares@ US$0.88Common StockSEC:0001144204-13-066784:2
Canonical exit: 11 Mar 2014 (T+90)
2,500 shares@ US$1.06Common StockSEC:0001144204-13-065520:0
Canonical exit: 25 Feb 2014 (T+90)
600 shares@ US$1.09Common StockSEC:0001144204-13-065520:1
Canonical exit: 27 Feb 2014 (T+90)
1,700 shares@ US$1.05Common StockSEC:0001144204-13-065520:2
Canonical exit: 2 Mar 2014 (T+90)
638,188 shares0Common StockSEC:0001144204-13-051590:0
16 of 16 declarations
